Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pharmacokinetic-pharmacodynamic Modeling and Simulation Study of Subcutaneous Infliximab in Patients With Inflammatory Bowel Disease

NCT07120152 is registered in ClinicalTrials.gov with Erwin Dreesen as lead sponsor.

NCT NCT07120152
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07120152 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pharmacokinetic-pharmacodynamic Modeling and Simulation Study of Subcutaneous Infliximab in Patients With Inflammatory Bowel Disease
Lead sponsor
Erwin Dreesen
Phase
Observational
Overall status
Not yet recruiting
Start date
September 1, 2025
Completion date
March 1, 2027
Enrollment
439 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ibd - inflammatory bowel disease, ra - rheumatoid arthritis